Kromek Group PLC (LON:KMK) is celebrating repeat orders worth around US$1.15mln for its detector modules from three of its original equipment manufacturer (OEM) customers.
The radiation detection technology company said the orders are from global producers and exporters of bone mineral diagnostic [BMD] systems that incorporate Kromek’s cadmium zinc telluride-based detector modules.
The Kromek investment case
Read Contract wins underpin full-year expectations at Kromek
See Kromek celebrating milestone week – interview with CEO Dr Arnab Basu
The contracts are expected to be delivered over the next 24 months, with the bulk of the orders expected to be shipped within the next 12 months.
Kromek's detector modules will be incorporated into the OEMs' systems to produce some of the most accurate imaging to diagnose the strength and health of bones, Kromek said.
The CZT-based diagnostic systems will allow clinicians to accurately detect and monitor progression of osteoporosis in patients resulting in more effective treatment.
"It is very pleasing to secure double the orders we received from these long-standing customers last year,” said Dr Arnab Basu, the chief executive officer of Kromek.
“It strengthens our relationship with them and further validates our belief that more and more legacy detection systems are being replaced with BMD diagnostic systems with our CZT detectors. The agreements represent the continued healthy conversion of our pipeline into orders as we continue to win new contracts in the medical sector," he added.